A risk for returned travellers: The "post-antibiotic era"

Medical Journal of Australia

Volumn 193, Issue 1, 2010, Pages 59-

  Fernando, Geethanie A T P ^a   Collignon, Peter J ^a   Bell, Jan M ^b  

^a CANBERRA HOSPITAL   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; CIPROFLOXACIN; COLISTIN; MEROPENEM; NEW DELHI METALLO BETA LACTAMASE; TIGECYCLINE; UNCLASSIFIED DRUG;

ADULT; AUSTRALIA; BRAIN HYPOXIA; CASE REPORT; ELECTIVE SURGERY; HUMAN; INDIA; INTENSIVE CARE UNIT; LETTER; MULTIDRUG RESISTANCE; NONHUMAN; PROVIDENCIA RETTGERI; PSEUDOMONAS AERUGINOSA; RISK FACTOR; TRAVEL; UNITED KINGDOM; URINARY CATHETER;

EID: 77955604225     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb03747.x     Document Type: Letter

References (4)

1. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007; 20: 440-458.
2. IMP-4 among gram-negative pathogens in a clinical setting in Australia. Clin Infect Dis 2005; 41: 1549-1556.
3. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53: 5046-5054.
4. Health Protection Agency. National resistance alert: carbapanemases in Enterobacteriaceae. UK: Health Protection Report 2009; 3(4): 3-4. http:// www.hpa.org.uk/hpr/archives/2009/hpr0409.pdf (accessed May 2010).